Okta (OKTA) 10-Q 30 Aug 23 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jul. 31, 2023	Aug. 28, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	001-38044
Entity Registrant Name	Okta, Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	100 First Street, Suite 600
Entity Tax Identification Number	26-4175727
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	888
Local Phone Number	722-7871
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	OKTA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001660134
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		156,752,036
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		7,299,891

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 356,000	$ 264,000
Short-term investments	1,750,000	2,316,000
Accounts receivable, net of allowances of $7 and $8	388,000	481,000
Deferred commissions	101,000	92,000
Prepaid expenses and other current assets	91,000	76,000
Total current assets	2,686,000	3,229,000
Property and equipment, net	49,000	59,000
Operating lease right-of-use assets	92,000	122,000
Deferred commissions, noncurrent	218,000	210,000
Intangible assets, net	211,000	241,000
Goodwill	5,406,000	5,400,000
Other assets	51,000	46,000
Total assets	8,713,000	9,307,000
Current liabilities:
Accounts payable	13,000	12,000
Accrued expenses and other current liabilities	95,000	112,000
Accrued compensation	123,000	99,000
Deferred revenue	1,225,000	1,242,000
Total current liabilities	1,456,000	1,465,000
Convertible senior notes, net, noncurrent	1,451,000	2,193,000
Operating lease liabilities, noncurrent	122,000	142,000
Deferred revenue, noncurrent	17,000	18,000
Other liabilities, noncurrent	27,000	23,000
Total liabilities	3,073,000	3,841,000
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, par value $0.0001 per share; 100,000 shares authorized; no shares issued and outstanding as of July 31, 2023 and January 31, 2023	0	0
Additional paid-in capital	8,359,000	7,974,000
Accumulated other comprehensive loss	(14,000)	(33,000)
Accumulated deficit	(2,705,000)	(2,475,000)
Total stockholders’ equity	5,640,000	5,466,000
Total liabilities and stockholders' equity	8,713,000	9,307,000
Class A Common Stock
Stockholders’ equity:
Common stock	0	0
Class B Common Stock
Stockholders’ equity:
Common stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Allowance for accounts receivable	$ 7,000	$ 8,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	156,740,000	154,009,000
Common stock, shares outstanding (in shares)	156,740,000	154,009,000
Class B Common Stock
Common stock par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	120,000,000	120,000,000
Common stock, shares issued (in shares)	7,300,000	7,300,000
Common stock, shares outstanding (in shares)	7,300,000	7,300,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenue:
Total revenue	$ 556,000	$ 452,000	$ 1,074,000	$ 867,000
Cost of revenue:
Total cost of revenue	149,000	138,000	291,000	269,000
Gross profit	407,000	314,000	783,000	598,000
Operating expenses:
Research and development	172,000	156,000	335,000	318,000
Sales and marketing	261,000	265,000	517,000	517,000
General and administrative	119,000	101,000	229,000	211,000
Restructuring and other charges	17,000	0	24,000	0
Total operating expenses	569,000	522,000	1,105,000	1,046,000
Operating loss	(162,000)	(208,000)	(322,000)	(448,000)
Interest expense	(2,000)	(3,000)	(5,000)	(6,000)
Interest income and other, net	18,000	5,000	35,000	7,000
Gain on early extinguishment of debt	42,000	0	73,000	0
Interest and other, net	58,000	2,000	103,000	1,000
Loss before provision for income taxes	(104,000)	(206,000)	(219,000)	(447,000)
Provision for income taxes	7,000	4,000	11,000	6,000
Net loss	$ (111,000)	$ (210,000)	$ (230,000)	$ (453,000)
Net loss per share, basic (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)
Net loss per share, diluted (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)
Weighted-average shares used to compute net loss per share, basic (in shares)	162,755	157,400	162,051	156,650
Weighted-average shares used to compute net loss per share, diluted (in shares)	162,755	157,400	162,051	156,650
Subscription
Revenue:
Total revenue	$ 542,000	$ 435,000	$ 1,045,000	$ 833,000
Cost of revenue:
Total cost of revenue	128,000	117,000	250,000	228,000
Professional services and other
Revenue:
Total revenue	14,000	17,000	29,000	34,000
Cost of revenue:
Total cost of revenue	$ 21,000	$ 21,000	$ 41,000	$ 41,000

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (111,000)	$ (210,000)	$ (230,000)	$ (453,000)
Other comprehensive income (loss):
Net change in unrealized gains or losses on available-for-sale securities	3,000	(2,000)	14,000	(19,000)
Foreign currency translation adjustments	3,000	(3,000)	5,000	(10,000)
Other comprehensive income (loss)	6,000	(5,000)	19,000	(29,000)
Comprehensive loss	$ (105,000)	$ (215,000)	$ (211,000)	$ (482,000)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common stock and additional paid-in capital	Common stock and additional paid-in capital Adjustment	Accumulated deficit	Accumulated deficit Adjustment	Accumulated other comprehensive income
Beginning balance at Jan. 31, 2022		$ 7,750,000	$ (528,000)	$ (1,816,000)	$ 156,000	$ (12,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and other activity, net		30,000
Stock-based compensation		343,000
Settlement of convertible senior notes		12,000
Net loss	$ (453,000)			(453,000)
Other comprehensive income (loss)						(29,000)
Ending balance at Jul. 31, 2022	5,453,000	7,607,000		(2,113,000)		(41,000)
Beginning balance at Apr. 30, 2022		7,412,000		(1,903,000)		(36,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and other activity, net		23,000
Stock-based compensation		172,000
Net loss	(210,000)			(210,000)
Other comprehensive income (loss)						(5,000)
Ending balance at Jul. 31, 2022	5,453,000	7,607,000		(2,113,000)		(41,000)
Beginning balance at Jan. 31, 2023	5,466,000	7,974,000		(2,475,000)		(33,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and other activity, net		37,000
Stock-based compensation		352,000
Settlement of warrants		(4,000)
Net loss	(230,000)			(230,000)
Other comprehensive income (loss)						19,000
Ending balance at Jul. 31, 2023	5,640,000	8,359,000		(2,705,000)		(14,000)
Beginning balance at Apr. 30, 2023		8,148,000		(2,594,000)		(20,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and other activity, net		29,000
Stock-based compensation		186,000
Settlement of warrants		(4,000)
Net loss	(111,000)			(111,000)
Other comprehensive income (loss)						6,000
Ending balance at Jul. 31, 2023	$ 5,640,000	$ 8,359,000		$ (2,705,000)		$ (14,000)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Cash flows from operating activities:
Net loss	$ (111,000)	$ (210,000)	$ (230,000)	$ (453,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation			351,000	341,000
Depreciation, amortization and accretion			43,000	61,000
Amortization of debt issuance costs			2,000	2,000
Amortization of deferred commissions			49,000	39,000
Deferred income taxes			3,000	2,000
Lease impairment charges			25,000	0
Gain on early extinguishment of debt	(42,000)	0	(73,000)	0
Net gain on strategic investments			0	(2,000)
Other, net			4,000	2,000
Changes in operating assets and liabilities:
Accounts receivable			92,000	74,000
Deferred commissions			(65,000)	(50,000)
Prepaid expenses and other assets			(14,000)	(2,000)
Operating lease right-of-use assets			12,000	14,000
Accounts payable			1,000	24,000
Accrued compensation			24,000	(55,000)
Accrued expenses and other liabilities			(4,000)	1,000
Operating lease liabilities			(20,000)	(13,000)
Deferred revenue			(18,000)	15,000
Net cash provided by operating activities			182,000	0
Cash flows from investing activities:
Capitalized software			(7,000)	(6,000)
Purchases of property and equipment			(2,000)	(7,000)
Purchases of securities available-for-sale and other			(577,000)	(571,000)
Proceeds from maturities and redemption of securities available-for-sale			1,101,000	521,000
Proceeds from sales of securities available-for-sale and other			61,000	0
Purchases of intangible assets			0	(2,000)
Payments for business acquisitions, net of cash acquired			(22,000)	(4,000)
Net cash provided by (used in) investing activities			554,000	(69,000)
Cash flows from financing activities:
Payments for repurchases of convertible senior notes			(671,000)	0
Payments for warrants related to convertible senior notes	(4,000)		(4,000)	0
Proceeds from stock option exercises, net of repurchases			8,000	9,000
Proceeds from shares issued in connection with employee stock purchase plan			26,000	19,000
Net cash provided by (used in) financing activities			(641,000)	28,000
Effects of changes in foreign currency exchange rates on cash, cash equivalents and restricted cash			2,000	(6,000)
Net increase (decrease) in cash, cash equivalents and restricted cash			97,000	(47,000)
Cash, cash equivalents and restricted cash at beginning of period			271,000	273,000	$ 273,000
Cash, cash equivalents and restricted cash at end of period	368,000	226,000	368,000	226,000	271,000
Cash paid during the period for:
Cash payments included in the measurement of operating lease liabilities			24,000	18,000
Non-cash activities:
Issuance of common stock for conversions of convertible senior notes			0	40,000
Benefit from exercise of hedges related to convertible senior notes			2,000	18,000
Operating lease right-of-use assets exchanged for lease liabilities			5,000	8,000
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	356,000	216,000	356,000	216,000	264,000
Restricted cash, current included in prepaid expenses and other current assets	5,000	2,000	5,000	2,000
Restricted cash, noncurrent included in other assets	7,000	8,000	7,000	8,000
Total cash, cash equivalents and restricted cash	$ 368,000	$ 226,000	$ 368,000	$ 226,000	$ 271,000

Overview and Basis of Presentat

Overview and Basis of Presentation	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Description of Business Okta, Inc. (the “Company”) is the leading independent identity partner. The Company’s Workforce Identity and Customer Identity Clouds are powered by the Company’s Identity Platform enabling customers to securely connect the right people to the right technologies and services at the right time. Employees and contractors sign into the Workforce Identity Cloud to seamlessly and securely access the applications they need to do their most important work. Developers leverage the Workforce Identity and Customer Identity Clouds to securely and efficiently embed identity into the software they build, allowing them to innovate and focus on their core missions. Organizations use the Company’s Identity Platform to collaborate with their partners, and to provide their customers with more modern and secure experiences in the cloud and via mobile devices. The Company was incorporated in January 2009 as Saasure Inc., a California corporation, and was later reincorporated in April 2010 under the name Okta, Inc. as a Delaware corporation. The Company is headquartered in San Francisco, California. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements. All intercompany balances and transactions have been eliminated in consolidation. The Company conducts business globally and is managed, operated and organized by major functional departments that operate on a consolidated basis. As a result, the Company operates in one reportable segment. The condensed consolidated balance sheet as of January 31, 2023, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2024 or any future period. The Company’s fiscal year ends on January 31. References to fiscal 2024, for example, refer to the fiscal year ending January 31, 2024. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 3, 2023. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience and on other assumptions that management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the valuation of deferred income tax assets, uncertain tax positions, assets and liabilities acquired in business combinations, and loss contingencies related to litigation.

Accounting Standards and Signif

Accounting Standards and Significant Accounting Policies	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Accounting Standards and Significant Accounting Policies	Accounting Standards and Significant Accounting Policies Significant Accounting PoliciesFor a summary of the Company’s significant accounting policies refer to “Note 2. Summary of Significant Accounting Policies” of its Annual Report on Form 10-K for the fiscal year ended January 31, 2023.

Restructuring and Other Charges

Restructuring and Other Charges	6 Months Ended
	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	Restructuring and Other Charges During the third quarter of fiscal 2023, the Company announced a real estate optimization plan which provided for closing duplicative sites and decommissioning underutilized offices and floors. The Company recognized non-cash lease impairment charges of $14 million in the year ended January 31, 2023. In the three and six months ended July 31, 2023, the Company recognized an additional $17 million and $25 million, respectively, of non-cash lease impairment charges as a result of the real estate optimization plan. The non-cash lease impairment charges represent the amount that the carrying value of the asset groups exceeded their estimated fair values. The asset groups primarily include operating lease right-of-use assets, leasehold improvements, and related property and equipment. To estimate the fair value of the asset group, the Company utilized a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate. During the fourth quarter of fiscal 2023, the Company approved a restructuring plan (the “Restructuring Plan”) intended to reduce operating expenses and improve profitability. The Restructuring Plan involved a reduction of the Company’s workforce by approximately 300 full-time employees. The Restructuring Plan was substantially complete by the first quarter of fiscal 2024 and the Company recognized aggregate restructuring costs of $15 million in the fourth quarter of fiscal 2023. The following table summarizes the Company’s restructuring liability that is included in Accrued expenses and other current liabilities on the condensed consolidated balance sheet: Severance and termination benefit costs (dollars in millions) Balance as of January 31, 2023 $ 15 Cash payments (15) Balance as of July 31, 2023 $ —

Cash Equivalents and Investment

Cash Equivalents and Investments	6 Months Ended
	Jul. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Investments	Cash Equivalents and Investments Cash Equivalents and Short-term Investments In estimating fair value, the Company uses a three-tier fair value hierarchy as follows: • Level 1 — Valuations based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets. • Level 2 — Valuations based on other inputs that are directly or indirectly observable in the marketplace. • Level 3 — Valuations based on unobservable inputs that are supported by little or no market activity. The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments: As of July 31, 2023 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Level 1: Cash equivalents: Money market funds $ 223 $ — $ — $ 223 Total cash equivalents 223 — — 223 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 1,730 — (10) 1,720 Corporate debt securities 30 — — 30 Total short-term investments 1,760 — (10) 1,750 Total $ 1,983 $ — $ (10) $ 1,973 As of January 31, 2023 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Level 1: Cash equivalents: Money market funds $ 133 $ — $ — $ 133 Total cash equivalents 133 — — 133 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 2,207 — (22) 2,185 Corporate debt securities 133 — (2) 131 Total short-term investments 2,340 — (24) 2,316 Total $ 2,473 $ — $ (24) $ 2,449 The following table presents the contractual maturities of the Company’s short-term investments: As of July 31, 2023 Amortized Cost Estimated Fair Value (dollars in millions) Due within one year $ 1,564 $ 1,556 Due between one to five years 196 194 Total $ 1,760 $ 1,750 Interest receivable of $15 million and $10 million is included in Prepaid expenses and other current assets on the condensed consolidated balance sheets as of July 31, 2023 and January 31, 2023, respectively. The following table presents the fair values and unrealized losses related to the Company’s investments in available-for-sale debt securities classified by length of time that the securities have been in a continuous unrealized loss position as of July 31, 2023: Less Than 12 Months More Than 12 Months Total Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses (dollars in millions) U.S. treasury securities $ 1,248 $ (5) $ 447 $ (5) $ 1,695 $ (10) Corporate debt securities 18 — 12 — 30 — Total $ 1,266 $ (5) $ 459 $ (5) $ 1,725 $ (10) The Company had 111 and 159 short-term investments in unrealized loss positions as of July 31, 2023 and January 31, 2023, respectively. For available-for-sale debt securities that have unrealized losses, the Company evaluates whether (i) the Company has the intention to sell any of these investments, (ii) it is not more likely than not that the Company will be required to sell any of these available-for-sale debt securities before recovery of the entire amortized cost basis and (iii) the decline in the fair value of the investment is due to credit or non-credit related factors. There were no material credit or non-credit related impairments for short-term investments as of July 31, 2023 and January 31, 2023. Strategic Investments Strategic investments primarily include equity investments in privately-held companies, which do not have a readily determinable fair value. As of July 31, 2023 and January 31, 2023, the balance of strategic investments was $28 million and $25 million, respectively.

Deferred Commissions

Deferred Commissions	6 Months Ended
	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred Commissions	Deferred Commissions Sales commissions capitalized as contract costs totaled $40 million and $28 million in the three months ended July 31, 2023 and 2022, respectively, and $65 million and $49 million in the six months ended July 31, 2023 and 2022, respectively. Amortization of contract costs totaled $26 million and $21 million for the three months ended July 31, 2023 and 2022, respectively, and $49 million and $40 million for the six months ended July 31, 2023 and 2022, respectively. Deferred Revenue Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met. Subscription revenue recognized during the three months ended July 31, 2023 and 2022 that was included in the deferred revenue balances at the beginning of the respective periods was $490 million and $390 million, respectively, and $850 million and $657 million in the six months ended July 31, 2023 and 2022, respectively. Professional services and other revenue recognized during the three months ended July 31, 2023 and 2022 that was included in the deferred revenue balances at the beginning of the respective periods was $4 million and $7 million, respectively, and $6 million and $11 million in the six months ended July 31, 2023 and 2022, respectively. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. Total remaining non-cancelable performance obligations under subscription contracts with customers was approximately $3,027 million as of July 31, 2023 . Of this amount, the Company expects to recognize revenue of approximately $1,772 million, or 59%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of July 31, 2023 were not material.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	6 Months Ended
	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Commissions Sales commissions capitalized as contract costs totaled $40 million and $28 million in the three months ended July 31, 2023 and 2022, respectively, and $65 million and $49 million in the six months ended July 31, 2023 and 2022, respectively. Amortization of contract costs totaled $26 million and $21 million for the three months ended July 31, 2023 and 2022, respectively, and $49 million and $40 million for the six months ended July 31, 2023 and 2022, respectively. Deferred Revenue Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met. Subscription revenue recognized during the three months ended July 31, 2023 and 2022 that was included in the deferred revenue balances at the beginning of the respective periods was $490 million and $390 million, respectively, and $850 million and $657 million in the six months ended July 31, 2023 and 2022, respectively. Professional services and other revenue recognized during the three months ended July 31, 2023 and 2022 that was included in the deferred revenue balances at the beginning of the respective periods was $4 million and $7 million, respectively, and $6 million and $11 million in the six months ended July 31, 2023 and 2022, respectively. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. Total remaining non-cancelable performance obligations under subscription contracts with customers was approximately $3,027 million as of July 31, 2023 . Of this amount, the Company expects to recognize revenue of approximately $1,772 million, or 59%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of July 31, 2023 were not material.

Convertible Senior Notes, Net

Convertible Senior Notes, Net	6 Months Ended
	Jul. 31, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes, Net	Convertible Senior Notes, Net Convertible Senior Notes The 2025 convertible senior notes (“2025 Notes”) and the 2026 convertible senior notes (“2026 Notes” and together with the 2025 Notes, the “Notes”) are recorded at face value less unamortized debt issuance costs. During the three months ended July 31, 2023, the Company repurchased $142 million principal amount of the 2025 Notes for $130 million in cash and $242 million principal amount of the 2026 Notes for $209 million in cash, resulting in a gain on early extinguishment of debt of $42 million. During the six months ended July 31, 2023, the Company repurchased $508 million principal amount of the 2025 Notes for $462 million in cash and $242 million principal amount of the 2026 Notes for $209 million in cash, resulting in a gain on early extinguishment of debt of $73 million. The net carrying amount of the Notes consisted of the following: As of July 31, 2023 As of January 31, 2023 (dollars in millions) 2025 Notes: Principal $ 552 $ 1,060 Less: unamortized debt issuance costs (3) (8) Net carrying amount $ 549 $ 1,052 2026 Notes: Principal $ 908 $ 1,150 Less: unamortized debt issuance costs (6) (9) Net carrying amount $ 902 $ 1,141 Fair Value Measurements The following table presents the principal amounts and estimated fair values of the Notes, which are not recorded at fair value on the condensed consolidated balance sheets: As of July 31, 2023 Principal Amount Estimated Fair Value (dollars in millions) 2025 Notes $ 552 $ 502 2026 Notes $ 908 $ 787 The estimated fair values of the Notes, which are Level 2 financial instruments, were determined based on the quoted bid prices of the Notes in an over-the-counter market on the last trading day of the reporting period. Warrants In February 2018, the Company sold net-share-settled (or, at the Company’s election subject to certain conditions, cash-settled) warrants (the “Warrants”) to acquire shares of the Company’s Class A common stock at an initial exercise price of approximately $68.06 per share. The Warrants may be exercised over 80 scheduled trading days beginning on May 15, 2023 and will expire if they are not exercised on their respective exercise dates. The Company has elected to cash settle the Warrants.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Letters of Credit In conjunction with the execution of certain office space operating leases, letters of credit in the aggregate amount of $11 million and $6 million were issued and outstanding as of July 31, 2023 and January 31, 2023, respectively. No draws have been made under such letters of credit. Legal Matters From time to time in the normal course of business, the Company may be subject to various legal matters such as threatened or pending claims or proceedings. On May 20, 2022, a purported shareholder filed a putative class action lawsuit in the United States District Court for the Northern District of California against the Company and certain of its executive officers, captioned In re Okta, Inc. Securities Litigation, No. 3:22-cv-02990. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alleging that the defendants made false or misleading statements or omissions concerning the Company’s cybersecurity controls, vulnerability to data breaches, and the Company’s integration of Auth0, Inc. (“Auth0”). The lawsuit seeks an order certifying the lawsuit as a class action and unspecified damages. The defendants moved to dismiss the amended complaint. On March 31, 2023, the court issued an order granting in part and denying in part the motion to dismiss. The court dismissed in full the claims based on the plaintiff’s allegations related to the Company’s cybersecurity controls and vulnerability to data breaches, and dismissed in part and denied in part the claims based on allegations related to the Auth0 integration. Discovery is proceeding with respect to the issues remaining in the case. Additionally, two purported shareholders filed derivative lawsuits on behalf of the Company in the United States District Court for the Northern District of California against certain of its current and former executive officers and directors, captioned O’Dell v. McKinnon et al. , No. 3:22-cv-07480 (filed Nov. 28, 2022), and LR Trust v. McKinnon et al ., No. 3:22-cv-08627 (filed Dec. 13, 2022). The lawsuits allege, among other things, that the defendants breached their fiduciary duties by making false or misleading statements or omissions concerning the Company’s cybersecurity controls, vulnerability to data breaches, and the Company’s integration of Auth0. The lawsuits seek orders permitting the plaintiffs to maintain the actions derivatively on behalf of the Company, awarding unspecified damages allegedly sustained by the Company, awarding restitution from the individual defendants, and requiring the Company to make certain reforms to its corporate governance and controls. On February 22, 2023, the court entered a stipulated order consolidating the derivative actions, appointing co-lead counsel for plaintiffs, and staying the consolidated derivative actions during the pendency of the motion to dismiss in the securities class action lawsuit. The consolidated derivative action is captioned In re Okta, Inc. Stockholder Derivative Litigation , No. 3:22-cv-07480. On May 9, 2023, the court entered a stipulated order continuing the stay through the close of discovery in the securities class action lawsuit. On April 14, 2023, another shareholder filed a substantially similar derivative lawsuit in the United States District Court for the District of Delaware against certain of the Company’s current and former executive officers and directors, captioned Buono v. McKinnon et al. , No. 1:23-cv-00413. On May 31, 2023, the court entered a stipulated order whereby the defendants agreed to accept service and stay the derivative action through the close of discovery in the securities class action lawsuit. The Company is defending these lawsuits vigorously. At this time, the Company is unable to predict the outcome or estimate the amount of loss or range of losses that could potentially result from these lawsuits. Warranties and Indemnification To date, the Company has not incurred significant costs and has not accrued any material liabilities in the accompanying condensed consolidated financial statements as a result of its warranty and indemnification obligations.

Employee Incentive Plans

Employee Incentive Plans	6 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Employee Incentive Plans	Employee Incentive Plans The Company’s equity incentive plans provide for granting stock options, restricted stock units (“RSUs”), restricted stock awards (“RSAs”) to employees, consultants, officers and directors and restricted stock units with market-based vesting conditions to certain executives. In addition, the Company offers an Employee Stock Purchase Plan (“ESPP”) to eligible employees. Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations: Three Months Ended Six Months Ended 2023 2022 2023 2022 (dollars in millions) Cost of revenue Subscription $ 21 $ 18 $ 37 $ 35 Professional services and other 4 3 8 7 Research and development 74 70 142 140 Sales and marketing 41 39 79 78 General and administrative 45 40 85 81 Total $ 185 $ 170 $ 351 $ 341 The following table presents total unrecognized stock-based compensation expense related to outstanding equity awards as of July 31, 2023: Unrecognized Stock-based Compensation Expense Weighted-average remaining period Unvested RSUs $ 1,212 2.7 years Unvested RSAs 85 0.8 years Unvested stock options 51 1.4 years ESPP 10 0.5 years Total $ 1,358 Market-based Restricted Stock Units In March 2023, the Company granted market-based RSUs to certain members of management. The target number of market-based RSUs granted was 192,843. One-third of these market-based RSUs vest over each of a one-, two- and three-year performance period, each starting on February 1, 2023. The number of shares that can be earned ranges from 0% to 200% of the target number of shares based on the relative performance of the per share price of the Company’s common stock as compared to the Nasdaq Composite Index over the respective performance periods and subject to continuous employment through the vesting dates. The $149.78 average grant date fair value per target market-based RSU was determined using a Monte Carlo simulation approach. Compensation expense for awards with market conditions is recognized over the service period using the accelerated attribution method and is not reversed if the market condition is not met.

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesFor the three and six months ended July 31, 2023, the Company recorded a tax provision of $7 million and $11 million on pretax losses of $104 million and $219 million, respectively. The effective tax rate for the three and six months ended July 31, 2023 was approximately (6.5)% and (5.0)%, respectively. The effective tax rate differs from the statutory rate primarily as a result of a full valuation allowance against the U.S. deferred tax assets, the tax effect of foreign operations, U.S. federal and state taxes, and shortfalls from stock-based compensation.The Tax Cuts and Jobs Act enacted on December 22, 2017 amended Internal Revenue Code Section 174 to require that specific research and experimental (“R&E”) expenditures be capitalized and amortized over five years (U.S. R&E) or fifteen years (non-U.S. R&E) beginning in the Company's fiscal 2023. As a result, the Company utilized federal and state tax attributes and incurred cash taxes and tax expense.For the three and six months ended July 31, 2022, the Company recorded a tax provision of $4 million and $6 million on pretax losses of $206 million and $447 million, respectively. The effective tax rate for the three and six months ended July 31, 2022 was approximately (2.0)% and (1.4)%, respectively. The effective tax rate differs from the statutory rate primarily as a result of a full valuation allowance against the U.S. deferred tax assets, the tax effect of foreign operations, and U.S. state taxes

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The Company computes net loss per share of common stock in conformity with the two-class method required for participating securities. The following table presents the calculation of basic and diluted net loss per share: Three Months Ended Six Months Ended 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B (dollars in millions, shares in thousands, except per share data) Numerator: Net loss $ (106) $ (5) $ (201) $ (9) $ (220) $ (10) $ (433) $ (20) Denominator: Weighted-average shares outstanding, basic and diluted 155,455 7,300 150,409 6,991 154,751 7,300 149,666 6,984 Net loss per share, basic and diluted $ (0.68) $ (0.68) $ (1.34) $ (1.34) $ (1.42) $ (1.42) $ (2.89) $ (2.89) As the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of July 31, 2023 2022 (shares in thousands) Issued and outstanding stock options 5,668 7,264 Unvested RSUs issued and outstanding 11,340 8,648 Unvested market-based RSUs issued and outstanding 475 116 Unvested RSAs issued and outstanding 422 859 Shares committed under the ESPP 415 626 Shares related to the 2023 Notes — 108 Shares subject to warrants related to the issuance of the 2023 Notes 354 1,048 Shares related to the 2025 Notes 2,925 5,617 Shares related to the 2026 Notes 3,806 4,820 25,405 29,106

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (111,000)	$ (210,000)	$ (230,000)	$ (453,000)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Jul. 31, 2023 shares	Jul. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Larissa Schwartz [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On July 14, 2023, Larissa Schwartz, Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement (the “10b5-1 Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The 10b5-1 Plan allows for the sale of up to: (i) 3,624 shares of our Class A common stock, plus (ii) 100% of the net shares of our Class A common stock acquired by Ms. Schwartz resulting from the vesting of 5,319 RSUs (net of shares sold to cover her tax liability in connection with vesting), plus (iii) 33% of the net shares of our Class A common stock acquired by Ms. Schwartz resulting from the vesting of 5,320 RSUs (net of shares sold to cover her tax liability in connection with vesting); each at specific market prices, commencing on October 13, 2023 and continuing until all shares are sold or January 19, 2024, whichever comes first.
Name	Larissa Schwartz
Title	Chief Legal Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	July 14, 2023
Arrangement Duration	98 days
Larissa Schwartz Trading Arrangement, Class A Common Stock [Member] | Larissa Schwartz [Member]
Trading Arrangements, by Individual
Aggregate Available	3,624	3,624
Larissa Schwartz Trading Arrangement, 100% Class A Common Stock, RSUs Vested [Member] | Larissa Schwartz [Member]
Trading Arrangements, by Individual
Aggregate Available	5,319	5,319
Larissa Schwartz Trading Arrangement, 33% Class A Common Stock, RSUs Vested [Member] | Larissa Schwartz [Member]
Trading Arrangements, by Individual
Aggregate Available	5,320	5,320

Accounting Standards and Sign_2

Accounting Standards and Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements.
Principles of Consolidation	All intercompany balances and transactions have been eliminated in consolidation. The Company conducts business globally and is managed, operated and organized by major functional departments that operate on a consolidated basis. As a result, the Company operates in one reportable segment. The condensed consolidated balance sheet as of January 31, 2023, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2024 or any future period.
Fiscal Period	The Company’s fiscal year ends on January 31. References to fiscal 2024, for example, refer to the fiscal year ending January 31, 2024.
Use of Estimates	The preparation of condensed consolidated financial statements in conformity with GAAP requires estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience and on other assumptions that management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the valuation of deferred income tax assets, uncertain tax positions, assets and liabilities acquired in business combinations, and loss contingencies related to litigation.

Restructuring and Other Charg_2

Restructuring and Other Charges (Tables)	6 Months Ended
	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve	The following table summarizes the Company’s restructuring liability that is included in Accrued expenses and other current liabilities on the condensed consolidated balance sheet: Severance and termination benefit costs (dollars in millions) Balance as of January 31, 2023 $ 15 Cash payments (15) Balance as of July 31, 2023 $ —

Cash Equivalents and Investme_2

Cash Equivalents and Investments (Tables)	6 Months Ended
	Jul. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments	The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments: As of July 31, 2023 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Level 1: Cash equivalents: Money market funds $ 223 $ — $ — $ 223 Total cash equivalents 223 — — 223 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 1,730 — (10) 1,720 Corporate debt securities 30 — — 30 Total short-term investments 1,760 — (10) 1,750 Total $ 1,983 $ — $ (10) $ 1,973 As of January 31, 2023 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Level 1: Cash equivalents: Money market funds $ 133 $ — $ — $ 133 Total cash equivalents 133 — — 133 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 2,207 — (22) 2,185 Corporate debt securities 133 — (2) 131 Total short-term investments 2,340 — (24) 2,316 Total $ 2,473 $ — $ (24) $ 2,449
Schedule of Contractual Maturities of Short-term Investments	The following table presents the contractual maturities of the Company’s short-term investments: As of July 31, 2023 Amortized Cost Estimated Fair Value (dollars in millions) Due within one year $ 1,564 $ 1,556 Due between one to five years 196 194 Total $ 1,760 $ 1,750
Schedule of Unrealized Loss Position and Fair Value of Debt Securities	The following table presents the fair values and unrealized losses related to the Company’s investments in available-for-sale debt securities classified by length of time that the securities have been in a continuous unrealized loss position as of July 31, 2023: Less Than 12 Months More Than 12 Months Total Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses (dollars in millions) U.S. treasury securities $ 1,248 $ (5) $ 447 $ (5) $ 1,695 $ (10) Corporate debt securities 18 — 12 — 30 — Total $ 1,266 $ (5) $ 459 $ (5) $ 1,725 $ (10)

Convertible Senior Notes, Net (

Convertible Senior Notes, Net (Tables)	6 Months Ended
	Jul. 31, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The net carrying amount of the Notes consisted of the following: As of July 31, 2023 As of January 31, 2023 (dollars in millions) 2025 Notes: Principal $ 552 $ 1,060 Less: unamortized debt issuance costs (3) (8) Net carrying amount $ 549 $ 1,052 2026 Notes: Principal $ 908 $ 1,150 Less: unamortized debt issuance costs (6) (9) Net carrying amount $ 902 $ 1,141
Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note	The following table presents the principal amounts and estimated fair values of the Notes, which are not recorded at fair value on the condensed consolidated balance sheets: As of July 31, 2023 Principal Amount Estimated Fair Value (dollars in millions) 2025 Notes $ 552 $ 502 2026 Notes $ 908 $ 787

Employee Incentive Plans (Table

Employee Incentive Plans (Tables)	6 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense by Statement of Operations Location	Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations: Three Months Ended Six Months Ended 2023 2022 2023 2022 (dollars in millions) Cost of revenue Subscription $ 21 $ 18 $ 37 $ 35 Professional services and other 4 3 8 7 Research and development 74 70 142 140 Sales and marketing 41 39 79 78 General and administrative 45 40 85 81 Total $ 185 $ 170 $ 351 $ 341
Schedule of Unrecognized Stock-based Compensation Expense	The following table presents total unrecognized stock-based compensation expense related to outstanding equity awards as of July 31, 2023: Unrecognized Stock-based Compensation Expense Weighted-average remaining period Unvested RSUs $ 1,212 2.7 years Unvested RSAs 85 0.8 years Unvested stock options 51 1.4 years ESPP 10 0.5 years Total $ 1,358

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share: Three Months Ended Six Months Ended 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B (dollars in millions, shares in thousands, except per share data) Numerator: Net loss $ (106) $ (5) $ (201) $ (9) $ (220) $ (10) $ (433) $ (20) Denominator: Weighted-average shares outstanding, basic and diluted 155,455 7,300 150,409 6,991 154,751 7,300 149,666 6,984 Net loss per share, basic and diluted $ (0.68) $ (0.68) $ (1.34) $ (1.34) $ (1.42) $ (1.42) $ (2.89) $ (2.89)
Schedule of Potentially Dilutive Securities Excluded from Diluted Per Share Calculation	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of July 31, 2023 2022 (shares in thousands) Issued and outstanding stock options 5,668 7,264 Unvested RSUs issued and outstanding 11,340 8,648 Unvested market-based RSUs issued and outstanding 475 116 Unvested RSAs issued and outstanding 422 859 Shares committed under the ESPP 415 626 Shares related to the 2023 Notes — 108 Shares subject to warrants related to the issuance of the 2023 Notes 354 1,048 Shares related to the 2025 Notes 2,925 5,617 Shares related to the 2026 Notes 3,806 4,820 25,405 29,106

Overview and Basis of Present_2

Overview and Basis of Presentation (Details)	6 Months Ended
	Jul. 31, 2023 tradingDay
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	1
Number of reportable segments	1

Restructuring and Other Charg_3

Restructuring and Other Charges - Narrative (Details) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2023 USD ($)	Jan. 31, 2023 USD ($) employee	Jul. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)	Jan. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Lease impairment charges			$ 25	$ 0
Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Lease impairment charges	$ 17		$ 25		$ 14
Restructuring cost, number of positions eliminated | employee		300
Restructuring charges		$ 15

Restructuring and Other Charg_4

Restructuring and Other Charges - Schedule of Restructuring Reserve (Details) - Severance and termination benefit costs - Restructuring Plan $ in Millions	6 Months Ended
	Jul. 31, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Balance as of January 31, 2023	$ 15
Cash payments	(15)
Balance as of July 31, 2023	$ 0

Cash Equivalents and Investme_3

Cash Equivalents and Investments - Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Millions	Jul. 31, 2023	Jan. 31, 2023
Cash and Cash Equivalents [Line Items]
Amortized Cost	$ 1,983	$ 2,473
Unrealized Gain	0	0
Unrealized Loss	(10)	(24)
Estimated Fair Value	1,973	2,449
Cash Equivalents
Cash and Cash Equivalents [Line Items]
Amortized Cost	223	133
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	223	133
Cash Equivalents | Money market funds
Cash and Cash Equivalents [Line Items]
Amortized Cost	223	133
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	223	133
Short-term investments (Available-for-sale)
Cash and Cash Equivalents [Line Items]
Amortized Cost	1,760	2,340
Unrealized Gain	0	0
Unrealized Loss	(10)	(24)
Estimated Fair Value	1,750	2,316
Short-term investments (Available-for-sale) | U.S. treasury securities
Cash and Cash Equivalents [Line Items]
Amortized Cost	1,730	2,207
Unrealized Gain	0	0
Unrealized Loss	(10)	(22)
Estimated Fair Value	1,720	2,185
Short-term investments (Available-for-sale) | Corporate debt securities
Cash and Cash Equivalents [Line Items]
Amortized Cost	30	133
Unrealized Gain	0	0
Unrealized Loss	0	(2)
Estimated Fair Value	$ 30	$ 131

Cash Equivalents and Investme_4

Cash Equivalents and Investments - Schedule of Contractual Maturities of Short-term Investments (Details) - USD ($) $ in Millions	Jul. 31, 2023	Jan. 31, 2023
Amortized Cost
Amortized Cost	$ 1,983	$ 2,473
Estimated Fair Value
Estimated fair value	1,973	2,449
Short-term investments (Available-for-sale)
Amortized Cost
Amortized cost, due within one year	1,564
Amortized cost, due between one to five years	196
Amortized Cost	1,760	2,340
Estimated Fair Value
Estimated fair value, due within one year	1,556
Estimated fair value, due between one to five years	194
Estimated fair value	$ 1,750	$ 2,316

Cash Equivalents and Investme_5

Cash Equivalents and Investments - Narrative (Details)	6 Months Ended	12 Months Ended
	Jul. 31, 2023 USD ($) investment	Jan. 31, 2023 USD ($) investment
Investments, Debt and Equity Securities [Abstract]
Interest receivable	$ 15,000,000	$ 10,000,000
Number of short-term investments in unrealized loss positions (in investments) | investment	111	159
Other-than-temporary impairment short term investment	$ 0	$ 0
Strategic investments without a readily determinable fair value	$ 28,000,000	$ 25,000,000

Cash Equivalents and Investme_6

Cash Equivalents and Investments - Schedule of Unrealized Loss Position and Fair Value of Debt Securities (Details) $ in Millions	Jul. 31, 2023 USD ($)
Schedule of Investments [Line Items]
Estimated Fair Value, Less Than 12 Months	$ 1,266
Unrealized Losses, Less Than 12 Months	(5)
Estimated Fair Value, More Than 12 Months	459
Unrealized Losses, More Than 12 Months	(5)
Estimated Fair Value	1,725
Unrealized Losses	(10)
U.S. treasury securities
Schedule of Investments [Line Items]
Estimated Fair Value, Less Than 12 Months	1,248
Unrealized Losses, Less Than 12 Months	(5)
Estimated Fair Value, More Than 12 Months	447
Unrealized Losses, More Than 12 Months	(5)
Estimated Fair Value	1,695
Unrealized Losses	(10)
Corporate debt securities
Schedule of Investments [Line Items]
Estimated Fair Value, Less Than 12 Months	18
Unrealized Losses, Less Than 12 Months	0
Estimated Fair Value, More Than 12 Months	12
Unrealized Losses, More Than 12 Months	0
Estimated Fair Value	30
Unrealized Losses	$ 0

Deferred Commissions (Details)

Deferred Commissions (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Sales commissions capitalized as contract costs	$ 40	$ 28	$ 65	$ 49
Amortization of contract costs	$ 26	$ 21	$ 49	$ 40

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue from remaining performance obligations	$ 3,027		$ 3,027
Subscription
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized that was included in the contract liability balance	490	$ 390	850	$ 657
Professional services and other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized that was included in the contract liability balance	4	$ 7	6	$ 11
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue from remaining performance obligations	$ 1,772		$ 1,772
Remaining performance obligation, percentage	59%		59%
Performance obligations expected to be satisfied, expected timing	12 months		12 months

Convertible Senior Notes, Net -

Convertible Senior Notes, Net - Narrative (Details) $ / shares in Units, $ in Thousands, shares in Millions		3 Months Ended		6 Months Ended
	May 15, 2023 tradingDay	Jul. 31, 2023 USD ($) shares	Jul. 31, 2022 USD ($)	Jul. 31, 2023 USD ($) shares	Jul. 31, 2022 USD ($)	Feb. 28, 2018 $ / shares
Debt Instrument [Line Items]
Gain on early extinguishment of debt		$ 42,000	$ 0	$ 73,000	$ 0
Value of shares issuable under warrants granted (in dollars per share) | $ / shares						$ 68.06
Threshold trading days | tradingDay	80
Warrants settled (in shares) | shares		0.7		0.7
Payments for repurchase of Warrants		$ 4,000		$ 4,000	$ 0
Number of warrants outstanding (in shares) | shares		0.4		0.4
Senior Notes
Debt Instrument [Line Items]
Gain on early extinguishment of debt		$ 42,000		$ 73,000
Senior Notes | 2025 Notes
Debt Instrument [Line Items]
Debt repurchased, principal amount		142,000		508,000
Debt repurchase, cash portion		130,000		462,000
Senior Notes | 2026 Notes
Debt Instrument [Line Items]
Debt repurchased, principal amount		242,000		242,000
Debt repurchase, cash portion		$ 209,000		$ 209,000

Convertible Senior Notes, Net_2

Convertible Senior Notes, Net - Schedule of Debt (Details) - Senior Notes - USD ($) $ in Millions	Jul. 31, 2023	Jan. 31, 2023
2025 Notes
Debt Instrument [Line Items]
Principal	$ 552	$ 1,060
Less: unamortized debt issuance costs	(3)	(8)
Net carrying amount	549	1,052
2026 Notes
Debt Instrument [Line Items]
Principal	908	1,150
Less: unamortized debt issuance costs	(6)	(9)
Net carrying amount	$ 902	$ 1,141

Convertible Senior Notes, Net_3

Convertible Senior Notes, Net - Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note (Details) - Senior Notes $ in Millions	Jul. 31, 2023 USD ($)
2025 Notes | Principal Amount
Debt Instrument [Line Items]
Convertible senior notes	$ 552
2025 Notes | Estimated Fair Value
Debt Instrument [Line Items]
Convertible senior notes	502
2026 Notes | Principal Amount
Debt Instrument [Line Items]
Convertible senior notes	908
2026 Notes | Estimated Fair Value
Debt Instrument [Line Items]
Convertible senior notes	$ 787

Commitments and Contingencies (

Commitments and Contingencies (Details)	1 Months Ended
	Dec. 13, 2022 plaintiff	Jul. 31, 2023 USD ($)	Jan. 31, 2023 USD ($)
Derivative Lawsuit
Other Commitments [Line Items]
Number of plaintiffs | plaintiff	2
Letter of Credit
Other Commitments [Line Items]
Letters of credit issued and outstanding		$ 11,000,000	$ 6,000,000
Draws on line of credit		$ 0	$ 0

Employee Incentive Plans - Sche

Employee Incentive Plans - Schedule of Stock-based Compensation Expense by Statement of Operations Location (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 185,000	$ 170,000	$ 351,000	$ 341,000
Subscription
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	21,000	18,000	37,000	35,000
Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	4,000	3,000	8,000	7,000
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	74,000	70,000	142,000	140,000
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	41,000	39,000	79,000	78,000
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 45,000	$ 40,000	$ 85,000	$ 81,000

Employee Incentive Plans - Sc_2

Employee Incentive Plans - Schedule of Unrecognized Stock-based Compensation Expense (Details) $ in Millions	6 Months Ended
	Jul. 31, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, stock option	$ 51
Total	1,358
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, non-stock option	$ 1,212
Weighted-average remaining period (in years)	2 years 8 months 12 days
RSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, non-stock option	$ 85
Weighted-average remaining period (in years)	9 months 18 days
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period (in years)	1 year 4 months 24 days
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, non-stock option	$ 10
Weighted-average remaining period (in years)	6 months

Employee Incentive Plans - Narr

Employee Incentive Plans - Narrative (Details) - Market-based RSUs	1 Months Ended
	Mar. 31, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted in period | shares	192,843
Award vesting period	3 years
Granted (in dollars per share) | $ / shares	$ 149.78
Performance period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33%
Performance period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33%
Performance period three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted	0%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted	200%

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 7,000	$ 4,000	$ 11,000	$ 6,000
Pretax losses	$ 104,000	$ 206,000	$ 219,000	$ 447,000
Effective income tax rate	(6.50%)	(2.00%)	(5.00%)	(1.40%)

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Numerator:
Net loss	$ (111,000)	$ (210,000)	$ (230,000)	$ (453,000)
Denominator:
Weighted-average shares used to compute net loss per share, basic (in shares)	162,755	157,400	162,051	156,650
Weighted-average shares used to compute net loss per share, diluted (in shares)	162,755	157,400	162,051	156,650
Net loss per share, basic (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)
Net loss per share, diluted (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)
Class A Common Stock
Numerator:
Net loss	$ (106,000)	$ (201,000)	$ (220,000)	$ (433,000)
Denominator:
Weighted-average shares used to compute net loss per share, basic (in shares)	155,455	150,409	154,751	149,666
Weighted-average shares used to compute net loss per share, diluted (in shares)	155,455	150,409	154,751	149,666
Net loss per share, basic (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)
Net loss per share, diluted (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)
Class B Common Stock
Numerator:
Net loss	$ (5,000)	$ (9,000)	$ (10,000)	$ (20,000)
Denominator:
Weighted-average shares used to compute net loss per share, basic (in shares)	7,300	6,991	7,300	6,984
Weighted-average shares used to compute net loss per share, diluted (in shares)	7,300	6,991	7,300	6,984
Net loss per share, basic (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)
Net loss per share, diluted (in dollars per share)	$ (0.68)	$ (1.34)	$ (1.42)	$ (2.89)

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Per Share (Details) - shares shares in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	25,405	29,106
Issued and outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	5,668	7,264
Unvested RSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	11,340	8,648
Unvested market-based RSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	475	116
Unvested RSAs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	422	859
Shares committed under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	415	626
Shares related to convertible senior notes | 2023 convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	108
Shares related to convertible senior notes | 2025 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,925	5,617
Shares related to convertible senior notes | 2026 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	3,806	4,820
Shares subject to warrants related to the issuance of the 2023 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	354	1,048

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	Feb. 28, 2018 $ / shares
Debt Instrument [Line Items]
Value of shares issuable under warrants granted (in dollars per share)	$ 68.06

Uncategorized Items - okta-2023

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]